paclitaxel has been researched along with Intestinal Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avagliano, C; Aviello, G; Cimmino, F; Coretti, L; Cristiano, C; Cuozzo, M; Lembo, F; Liguori, FM; Mollica, MP; Russo, R; Turco, L | 1 |
1 other study(ies) available for paclitaxel and Intestinal Diseases
| Article | Year |
|---|---|
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction.
Topics: Animals; Butyric Acid; Carcinoma, Non-Small-Cell Lung; Dietary Supplements; Gastrointestinal Microbiome; Intestinal Diseases; Lung Neoplasms; Mice; Mice, Inbred C57BL; Paclitaxel | 2022 |